实用肿瘤学杂志 ›› 2024, Vol. 38 ›› Issue (2): 121-130.doi: 10.11904/j.issn.1002-3070.2024.02.007

• 临床研究 • 上一篇    下一篇

基于免疫细胞浸润的免疫评分模型预测早期胃癌免疫治疗效果及预后

杨鹏1, 罗金梅1, 罗萍2, 谢小波3   

  1. 1.南充市嘉陵区人民医院消化内科(南充 637000);
    2.南充市嘉陵区中医医院内科;
    3.南充市嘉陵区人民医院风湿免疫科
  • 收稿日期:2023-06-13 修回日期:2024-02-28 出版日期:2024-04-28 发布日期:2024-07-12
  • 通讯作者: 杨鹏,E-mail:Yangpeng108866@163.com
  • 作者简介:杨鹏,男,(1981-),本科,主治医师,从事胃部肿瘤方面的研究。

An immune score model based on immune cell infiltration predicts the effects of immunotherapy and prognosis of early gastric cancer

YANG Peng1, LUO Jinmei1, LUO Ping2, XIE Xiaobo3   

  1. 1. Department of Gastroenterology,People's Hospital of Jialing District,Nanchong 637000,China;
    2. Department of Internal Medicine,Traditional Chinese Medicine Hospital of Jialing District;
    3. Department of Rheumatology and Immunology,People's Hospital of Jialing District
  • Received:2023-06-13 Revised:2024-02-28 Online:2024-04-28 Published:2024-07-12

摘要: 目的 分析基于免疫细胞浸润的免疫评分模型对早期胃癌免疫治疗效果及预后的预测价值。方法 从癌症基因组图谱(TCGA)数据库下载167例早期胃癌患者的基因表达数据及相关临床参数作为训练集;收集2017年1月—2020年1月于本院首次就诊的92例早期胃癌患者临床信息作为验证集进行外部验证。通过Cibersort软件计算肿瘤组织中22种免疫细胞的浸润情况。通过LASSO分析和多因素Cox回归分析进一步筛选和确定早期胃癌患者的关键预测因子。使用符合条件的免疫细胞构建预后风险评分模型,并进行验证。基于风险模型建立列线图模型预测早期胃癌患者死亡和治疗无效的概率,并对模型的区分度、准确度和可靠性进行评价。结果 训练集与验证集患者一般资料比较差异无统计学意义(P>0.05)。与正常组织相比,早期胃癌肿瘤组织中CD8+T细胞、激活记忆CD4+T细胞、M0巨噬细胞、M1巨噬细胞、静息树突状细胞和活化树突状细胞含量下降;调节性T细胞(Treg细胞)和嗜酸性粒细胞含量上升,差异具有统计学意义(P<0.05)。LASSO分析进一步筛选出激活记忆CD4+T细胞、M1巨噬细胞、Treg细胞、活化树突细胞及嗜酸性粒细胞5种浸润免疫细胞。生存曲线结果显示免疫评分模型可有效区分患者生存时间。预后列线图模型总分274分,对应死亡风险为72%;治疗效果列线图模型总分307分,对应治疗无效的风险为75%。模型验证结果显示列线图模型具有较高的区分度、准确度和可靠性。结论 基于免疫细胞浸润的免疫评分模型对早期胃癌患者免疫治疗效果及预后具有一定的预测价值。

关键词: 免疫细胞浸润, 免疫评分模型, 早期胃癌, 治疗效果, 预后

Abstract: Objective The aim of this study was to analyze the predictive value of an immune scoring model based on immune cell infiltration for the efficacy and prognosis of immunotherapy in early gastric cancer. Methods The gene expression data and related clinical parameters of 167 early gastric cancer patients were downloaded from the Cancer Genome Atlas(TCGA)as the training set.The clinical information of 92 early gastric cancer patients who first visited our hospital from January 2017 to January 2020 was collected as a validation set.The infiltration of 22 immune cells in tumor tissues was calculated by the Cibersort software.The key predictive factors for early gastric cancer patients were further screened and determined by lasso analysis and multivariate Cox regression analysis.The eligible immune cells were used to construct the prognostic risk scoring model and verify it.Based on the risk model,a nomograph model was established to predict the probability of death and treatment failure in early gastric cancer patients,and evaluate the differentiation,accuracy,and reliability of the model. Results There was no statistically significant difference in the general information of patients between the training set and the validation set(P>0.05).Compared with normal tissues,the content of CD8+T cells,activated memory CD4+T cells,M0 macrophages,M1 macrophages,resting dendritic cells,and activated dendritic cells in early gastric cancer tumor tissues decreased.The contents of regulatory T cells(Treg cells)and eosinophils increased,and the difference was statistically significant(P<0.05).The LASSO analysis further screened five types of infiltrating immune cells,including activated memory CD4+T cells,M1 macrophages,Treg cells,activated dendritic cells and eosinophils.The survival curve results showed that the immune scoring model could effectively distinguish the survival time of patients.The total score of the prognostic nomogram model was 274,corresponding to risk of death of 72%.The total score of the treatment effect nomograph model was 307,corresponding to a 75% risk of ineffective treatment.The model validation results showed that the nomograph model has high discrimination,accuracy and reliability. Conclusion The immune scoring model based on immune cell infiltration has a certain predictive value for the efficacy and prognosis of immunotherapy in patients with early gastric cancer.

Key words: Immune cell infiltration, Immune scoring model, Early gastric cancer, Therapeutic effects, Prognosis

中图分类号: